During the past decade, Randolph Hospital conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 80 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 42 clinical trials were completed. i.e. 323.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Randolph Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Randolph Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 88 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Randolph Hospital" are "Breast Cancer" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Colorectal Cancer" (6 trials) and "Lung Cancer" (6 trials). Many other conditions were trialed in "Randolph Hospital" in a lesser frequency.

Most popular intervention types in "Randolph Hospital" are "Drug" (109 trials), "Other" (78 trials), "Biological" (57 trials), "Procedure" (18 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (27 trials), "Paclitaxel" (19 trials), "Carboplatin" (17 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Randolph Hospital" are 92 trials for "All" genders, 38 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Randolph Hospital". undefined are not yet recruiting, 12 are recruiting, 50 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Randolph Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Randolph Hospital, 5 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 77 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".